Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Profound Medical (PROF) Invested Capital (2023 - 2025)

Historic Invested Capital for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $36.6 million.

  • Profound Medical's Invested Capital changed N/A to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 million, marking a year-over-year change of. This contributed to the annual value of $65.1 million for FY2024, which is 6980.54% up from last year.
  • As of Q3 2025, Profound Medical's Invested Capital stood at $36.6 million.
  • Over the past 5 years, Profound Medical's Invested Capital peaked at $65.1 million during Q4 2024, and registered a low of $36.6 million during Q3 2025.
  • Moreover, its 3-year median value for Invested Capital was $43.7 million (2025), whereas its average is $47.8 million.
  • The largest annual percentage gain for Profound Medical's Invested Capital in the last 5 years was 6980.54% (2024), contrasted with its biggest fall of 6980.54% (2024).
  • Over the past 3 years, Profound Medical's Invested Capital (Quarter) stood at $38.3 million in 2023, then skyrocketed by 69.81% to $65.1 million in 2024, then tumbled by 43.73% to $36.6 million in 2025.
  • Its Invested Capital stands at $36.6 million for Q3 2025, versus $43.7 million for Q2 2025 and $55.3 million for Q1 2025.